Internal Medicine, Infectious Disease · Boca Raton, FL
NPI
1154678811
Since 2012
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1200 N Federal Hwy # 221a
Boca Raton, FL, 33432
Phone (561) 961-0845
Groups this clinician bills Medicare through
Medicare paid, 2024
$77K
813 services
Medicare patients, 2024
269
Average age 76
Drug cost, 2024
$2.4M
2,451 prescriptions
Company payments, 2025
$137
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrea K Thet was code 99233 (hospital e&m - subsequent), 364 times for 148 patients. In total Andrea K Thet billed 813 services in 13 codes, and Medicare paid $77K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 364 | 148 | $95.61 | $35K |
| 99232 Hospital E&M - Subsequent | Facility | 197 | 60 | $63.45 | $12K |
| 99223 Hospital E&M - Initial | Facility | 125 | 117 | $140.79 | $18K |
| 99213 Office E&M - Established | Office | 41 | 37 | $73.19 | $3,001 |
| 99214 Office E&M - Established | Facility | 27 | 16 | $69.93 | $1,888 |
| 99214 Office E&M - Established | Office | 21 | 17 | $103.19 | $2,167 |
| 99215 Office E&M - Established | Office | 13 | 12 | $145.75 | $1,895 |
By year: 2022 $165K for 2,227 services; 2023 $17K for 170 services; 2024 $77K for 813 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrea K Thet prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 253 prescriptions and refills. In total Andrea K Thet wrote 2,451 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 253 | 271 | 37 | $1.0M |
| Atorvastatin Calcium Generic | 143 | 263 | 36 | $1,015 |
| Amlodipine Besylate Generic | 131 | 189 | 27 | $466 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 78 | 101 | 23 | $3,112 |
| Juluca Dolutegravir/Rilpivirine | 76 | 78 | Under 11 | $260K |
| Dovato Dolutegravir Sodium/Lamivudine | 71 | 77 | 11 | $225K |
| Gabapentin Generic | 61 | 87 | 18 | $671 |
| Omeprazole Generic | 55 | 70 | 14 | $476 |
| Metformin Hcl Generic | 53 | 89 | 14 | $240 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 49 | 53 | Under 11 | $212K |
| Hydrochlorothiazide Generic | 47 | 78 | Under 11 | $116 |
| Metoprolol Succinate Generic | 47 | 75 | Under 11 | $457 |
| Pravastatin Sodium Generic | 46 | 74 | Under 11 | $417 |
| Rosuvastatin Calcium Generic | 46 | 68 | Under 11 | $285 |
| Descovy Emtricitabine/Tenofov Alafenam | 41 | 41 | Under 11 | $88K |
Brand drugs: 796 claims; generic drugs: 1,639 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrea K Thet $137 ($137 in general payments such as food, travel and fees) from 2 companies. The largest payer was Gilead Sciences, Inc. with $122.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.